Lenskart Solutions is a technology-driven eyewear company with fully integrated operations across design, manufacturing, branding, and retailing of prescription eyeglasses, sunglasses, and contact lenses. It follows a D2C business model, selling the products under its own brands and sub-brands through both online and offline platforms.
The company commenced its operations in India as an online business in 2010 and opened its first retail store in New Delhi in 2013. Over the years, Lenskart Solutions has expanded its operations to Japan, Southeast Asia, the Middle East and other international markets. It is India's biggest organised retail seller of prescription eyewear and among the top 2 organised eyewear retailers in Asia according to B2C eyeglass sales volume in FY25.
Lenskart has a strong omnichannel retail network of 2,806 stores across the world (2,137 in India and 669 globally) with a total store footprint of 1.73 msf as of June 30, 2025. Its mobile apps had over 10 crore cumulative downloads along with a growing base of 1.24 crore annual transacting customer accounts with a 2-year repeat purchase rate of 3.62 eyeglasses per customer, 2x the Indian average of 1.8 eyeglasses.
The company operates a centralised and automated supply chain, with manufacturing facilities in Bhiwadi (Rajasthan) and Gurugram (Haryana), supported by regional units in Singapore and the UAE. Its Bhiwadi plant, one of the world's top 2 vertically integrated eyeglass manufacturing capacities, is 75% automated, which facilitates next-day delivery in 58 Indian cities. The company produces almost 70% of prescription eyeglasses in-house, with cost savings of 35–40% compared to usual retail stores, and with a 75% centralised inventory.
Lenskart Solutions' international expansion gained momentum after the acquisition of Owndays in 2022, which strengthened its presence in Japan and Southeast Asia. Together, Lenskart and Owndays operate across 14 countries, selling over 2.7 crore eyewear units collectively in FY25. Lenskart's innovation-driven model is also driven by technology and artificial intelligence. It has a 491-person strong technology team and applies AI-driven facial analysis, frame recommendation software, geo-analytic for store growth, and remote optometry services. It performed 1.35 crore eye tests and 0.26 crore eye tests outside India in FY25.
The company’s brand portfolio includes premium and affordable segments through John Jacobs, Owndays, Lenskart Air, Vincent Chase, hustlr, and Hooper Kids, with prescription eyeglasses accounting for more than 80% of its revenue from operations. In December 2024, it launched its affordable smart glasses category through “Phonic”, audio-enabled smart eyeglasses, in India. Lenskart was awarded “India’s Most Trusted Eyewear Brand 2025” by TRA Research in FY25. Its paid loyalty program, Lenskart Gold, had 0.71 crore members as of June 2025.
The global eyewear market, valued at ~₹15.2 lakh crore in FY25, is anticipated to grow to ~₹ 18.6 lakh crore by FY30. Asia accounts for 29-37% of the world's eyewear market as of FY25, and rising markets like India and Southeast Asia are estimated to be the quickest growing markets, with their organised eyewear market estimated to grow at ~19% and 10-14% respectively between FY25-FY30. This growth is fueled by heightened awareness of the prevalence of refractive errors, enhancing the affordability of prescription eyeglasses, and the increasing presence of organised players.
Lenskart is strategically positioned to capture the eyewear market expansion with operations across 14 countries and 669 international stores and regional facilities in Singapore and the UAE. The company’s focus remains on increasing market penetration, expanding customer access, innovating new product portfolios and enhancing customer experience.
Now, Lenskart Solutions Ltd is launching its initial public offering (IPO), which consists of a fresh issue of ₹2,150 and an offer for sale of ₹5,128.02 crore. The total issue size of the IPO is ₹7,278.02 crore. Its shares will be listed on the NSE and BSE.